During the target selection step of the medicines development process, scientists choose which abnormal process to focus on and correct in order to treat an illness.
Biologic medicines, or protein-based medicines such as insulin, are designed to interact with specific targets in the patient’s body. A more targeted mechanism of action should lead to a...
Once medicines have been administered and carried to the target by the bloodstream, their active ingredients interact with cells and in different ways, either by stimulating or inhibiting cellular...
